Health
India’s drug controller approves phase 2, 3 human trials of COVID-19 vaccine – China.org.cn
NEW DELHI, Aug. 3 (Xinhua) — Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) to conduct phase 2 and 3 human clinical trials of COVID-19 vaccine developed by Oxford University, officials said Monday.
“The DCGI has given approval to SII, Pune to conduct Phase II and III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the development of the COVID-19 vaccine,” a statement issued by country’s fed…
-
Noosa News24 hours agoAfter Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix
-
General21 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General17 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business17 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?